Inicio › Cáncer de próstata › Arkansas
Ensayos clínicos de Cáncer de próstata en Arkansas
13 estudios sobre Cáncer de próstata buscan participantes en Arkansas.
Ciudades en Arkansas
Texto oficial del estudio (inglés)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Mercy Hospital Fort Smith, Fort Smith
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 13 nov 2026 · NCT04423211Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 23 oct 2026 · NCT05946213Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Fayetteville
ReclutandoFase 1/2
Edades de 18 a 130 · Hombres · Actualizado el 22 oct 2026 · NCT07181161Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Hot Springs
- Research Site, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 15 oct 2026 · NCT07711002This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Highlands Oncology Group, PA, Fayetteville
- Highlands Oncology Group, PA, Rogers
- Highlands Oncology Group, PA, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 oct 2026 · NCT07028853Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 8 oct 2026 · NCT03678025Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Arkansas Urology Research Center, LLC, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 8 sept 2026 · NCT07224009AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
- University of Arkansas for Medical Sciences, Little Rock
Reclutando
Edades de 40 en adelante · Hombres · Actualizado el 19 ago 2026 · NCT07231627Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- Proton Center of Arkansas, Little Rock
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 17 jun 2026 · NCT00969111Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Highlands Oncology Group - Fayetteville, Fayetteville
- Highlands Oncology Group - Rogers, Rogers
- Highlands Oncology Group, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 ene 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.